Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5425
+0.0425 (8.50%)
At close: Nov 19, 2026, 4:00 PM EST
0.5409
-0.0016 (-0.29%)
After-hours: Nov 19, 2026, 7:58 PM EST
Humacyte Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Humacyte stock has a consensus rating of "Buy" and an average price target of $1.64. The average 1-year stock price forecast is 202.67% higher than the current stock price, while the lowest is $0.60 (+10.60%) and the highest is $4.00 (+637.33%).
Price Target: $1.64 (+202.67%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Humacyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $1 | Hold | Maintains | $1 | +84.33% | Nov 16, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $1.25 | Buy | Reiterates | $1.25 | +130.41% | Nov 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +637.33% | Nov 11, 2026 |
| BTIG | BTIG | Buy Maintains $2 | Buy | Maintains | $2 | +268.66% | Nov 11, 2026 |
| Barclays | Barclays | Hold Maintains $0.5 → $0.6 | Hold | Maintains | $0.5 → $0.6 | +10.60% | Nov 11, 2026 |
Financial Forecast
Revenue This Year
4.04M
from 2.04M
Increased by 98.07%
Revenue Next Year
23.44M
from 4.04M
Increased by 480.72%
EPS This Year
-0.37
from -0.26
EPS Next Year
-0.25
from -0.37
EPS and Forward PE are based on non-GAAP adjusted numbers.